Ashurst has advised Atomic Oncology Pty Ltd on the first tranche of its series seed round of fundraising.Atomic Oncology has developed a cancer diagnostic technology, ATIx,…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
